Daniel Stein is CEO of Embold Health, a leading-edge data analytics company he founded to improve health care by identifying and promoting high quality, high value medical providers. Embold Health believes that health care should be high-quality, medically appropriate based on the latest science and delivered cost-effectively.
Stein previously co-founded and served as chief medical officer for Walmart’s primary care clinic business, Walmart Care Clinics. He also formerly worked on the health staff of the U.S. Senate Finance Committee on policy related to Medicare and Medicaid. In this capacity, Stein worked extensively on the Medicare Modernization Act of 2003, Medicare prescription drug legislation and medical malpractice reform. In 2009, he returned to the U.S. Senate Finance Committee to help formulate health care workforce and delivery system reform proposals. Prior to that, Stein worked at the Centers for Medicare and Medicaid Services (CMS), focusing on Medicare quality and pay-for-performance initiatives.
Stein received his undergraduate degree in Ethics, Politics and Economics from Yale College; his medical degree from the Johns Hopkins School of Medicine; and his master’s degree in business administration from the Harvard Business School. He completed his residency in primary care internal medicine at Brigham and Women’s Hospital, where he was honored with the John H. McArthur Fellowship in Medicine and Management.